Optimal duration of dual antiplatelet therapy following PTA of the superficial femoral artery: the DAPT-SFA protocol

Aspirin; Clopidogrel; Drug Administration Schedule; Hemorrhage; Humans; Italy; Multicenter Studies as Topic; Peripheral Arterial Disease; Pilot Projects; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Time Factors; Treatment Outcome; Vascular Patency; Angioplasty; Femoral Artery